SenzaGen AB (OSTO:SENZA) Common Stock: kr1.63 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SENZA SenzaGen AB OSTO:SENZA
78 GF Score
Price kr5.34
GF Value kr6.43
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is SenzaGen AB Common Stock?

SenzaGen AB OSTO:SENZA +0.38% 78 Common Stock is kr1.63 Mil as of Mar. 2026. GuruFocus rates OSTO:SENZA with a GF Score™ of 78/100 and a GF Value™ of kr6.43 (Modestly Undervalued). The stock has 5 warning signs investors should review.

SenzaGen AB's quarterly common stock increased from Sep. 2025 (kr0.00 Mil) to Dec. 2025 (kr1.48 Mil) and increased from Dec. 2025 (kr1.48 Mil) to Mar. 2026 (kr1.63 Mil).

SenzaGen AB's annual common stock increased from Dec. 2023 (kr1.21 Mil) to Dec. 2024 (kr1.48 Mil) but then stayed the same from Dec. 2024 (kr1.48 Mil) to Dec. 2025 (kr1.48 Mil).

SenzaGen AB Common Stock Historical Data

* Premium members only.

The historical data trend for SenzaGen AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SenzaGen AB Common Stock Chart

SenzaGen AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.20 1.21 1.21 1.48 1.48

SenzaGen AB Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.48 1.63
OSTO:SENZA
78GF Score
SenzaGen AB OSTO:SENZA
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SenzaGen AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of kr1.63 Mil mean?
SenzaGen AB (OSTO:SENZA) has a Common Stock of kr1.63 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SenzaGen AB and its competitors.
Is SenzaGen AB's Common Stock too high?
SenzaGen AB's current Common Stock is kr1.63 Mil. Overall, SenzaGen AB has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SenzaGen AB's Common Stock compare to TMO and DHR?
SenzaGen AB's Common Stock of kr1.63 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SenzaGen AB and its competitors. SenzaGen AB's current Common Stock is kr1.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SenzaGen AB stock overvalued right now?
Based on GuruFocus' analysis, SenzaGen AB (OSTO:SENZA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr6.43, compared to a current price of kr5.34 — trading 17% below its estimated fair value. The current Common Stock is kr1.63 Mil. SenzaGen AB's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For SenzaGen AB (OSTO:SENZA), the current Common Stock is kr1.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SenzaGen AB (OSTO:SENZA) Overvalued in 2026?

Based on GuruFocus' analysis, SenzaGen AB stock appears to be undervalued. The current stock price of kr5.34 is trading 17% below its estimated GF Value™ of kr6.43. GuruFocus considers SenzaGen AB to be Modestly Undervalued.

Key valuation signals for OSTO:SENZA:

  • Common Stock: kr1.63 Mil
  • GF Value™: kr6.43 vs. price of kr5.34 (17% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the OSTO:SENZA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SenzaGen AB Business Description

Address Scheelevagen 8, Medicon Village, Building 401, Lund, SWE, 223 63
SenzaGen AB markets, sells, and performs in vitro testing using its Genomic Allergen Rapid Detection (GARD) platform through its laboratory and a network of contract research organizations. The company provides animal-free testing solutions for chemical compounds used in industries such as cosmetics, chemicals, pharmaceuticals, medical devices, and food and nutrition. Geographically, it operates in the Americas, EMEA, and APAC, with the majority of revenue from EMEA.
78GF Score

Get the complete analysis for OSTO:SENZA

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.34
Price
kr6.43
GF Value